← 返回首页
美国 · 平台与数据 · MarketWatch

The FDA declined to approve one of biotech’s most closely watched cancer drugs

来源:MarketWatch · 美国 32 分钟前
The FDA declined to approve one of biotech’s most closely watched cancer drugs
MarketWatch

详细摘要

The regulator told Summit Therapeutics that the lung-cancer drug needs to prove it can help people live longer.

在 MarketWatch 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketwatch.com)

推荐阅读